Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$47.45 - $58.05 $842,332 - $1.03 Million
-17,752 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$39.26 - $54.21 $181,577 - $250,721
4,625 Added 35.23%
17,752 $962,000
Q1 2019

May 08, 2019

BUY
$29.84 - $43.92 $391,709 - $576,537
13,127 New
13,127 $533,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.2B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Dean Investment Associates, LLC Portfolio

Follow Dean Investment Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dean Investment Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dean Investment Associates, LLC with notifications on news.